In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1834 News Items found
In the Lab
This image shows cancer cells (white) and pericytes (green) clinging to capillaries (red). The blue dots are nuclei.
Scientists Identify Growth Signal for Metastatic Cancer "Seeds"

Targeting this signal with drugs might be one way to stop cancers from spreading.
Q&A
Hand x ray
In Good Hands: Meet Hand Sarcoma Surgeon Edward Athanasian

Edward Athanasian discusses the unique challenges of operating on sarcomas and other tumors in the hand.
MSK patient Zachary Levine
Sunrise Day Camp: Where Kids with Cancer — and Their Siblings — Can Be Kids for the Summer

Discover how Sunrise Association Day Camps are transforming summer for children affected by cancer.
Finding
CT scans of brains
Research Advances the Genetic Understanding of Pineoblastoma, a Rare Brain Cancer

The findings will lead to more accurate diagnoses and, potentially, to better treatments.
In the Clinic
MSK surgeon José Guillem and patient Elliot Katz
A Family Discovers an Unexpected Cancer Risk in Their Genes

Two brothers discuss their surprise at being diagnosed with Lynch syndrome.
Finding
MSK computational biologist Barry Taylor
Double Jeopardy: Gene-Sequencing Test Uncovers New Clues about a Defect Seen in Many Tumors

MSK researchers have found that a genetic state in tumors called whole-genome doubling is connected with worse outcomes for people with cancer.
In the Lab
MSK physician-scientist Omar Abdel-Wahab
Splicing May Be an Effective Target in the Fight against Cancer

New drugs are being developed that target part of the process to make proteins.
In the Clinic
MSK sarcoma doctor William Tap with a patient
Six Things to Know about Soft Tissue Sarcoma Recurrence

If you've been treated for soft tissue sarcoma, a recurrence may be a big concern for you. Here's what MSK's sarcoma experts think you should know about the disease coming back.
MSK Researchers Have Identified a Doubling Chromosome That Can Help Predict Outcomes in People with Cancer

Experts at Memorial Sloan Kettering Cancer Center (MSK) have identified genome doubling in cancer and have correlated it to a worse prognosis across cancer types. Using MSK-IMPACT™ to analyze matched tumor and normal DNA, MSK researchers were able to identify an abnormality in tumors known as genome doubling. This doubling occurs in 28 percent of all cancers and could have significant implications for treatment options in the future.
Feature
Side-by-side images of brain MRIs.
New Imaging Technique Provides Snapshot of Brain Tumor Activity

A new imaging approach could shorten the time needed to determine whether a brain tumor treatment is working.